JBI’s three‑month performance (-3.6%) versus the S&P’s -13.1% is the standout, showing the stock can limit downside when market sentiment turns sharply negative—a trait that may appeal to defensive investors seeking relative stability in volatile periods.
The persistent negative long‑term trajectory—averaging -17% annually over 3‑5 years—means investors could still lose significant real purchasing power; a prolonged downturn in industrial demand or further margin pressure could accelerate losses, turning the relative outperformance into an absolute drag on portfolio returns.
The 3.43% drop in institutional ownership, while numerically small relative to the 91% base, translates to roughly $45 million of equity sold (assuming a $5 billion market cap), indicating that some large investors are trimming exposure; if this trend accelerates, it could pressure the stock price and undermine the current smart‑money bullish narrative.
The most notable growth driver is a 12% increase in service revenue mix, which now represents 22% of total sales; this higher‑margin segment improves profitability margins and signals a strategic shift toward more resilient, recurring income streams.
The primary margin risk is the exposure to volatile petrochemical input costs, which have risen 9% year‑over‑year; if passed through to customers at less than a one-to-one ratio, gross margin could compress by up to 150 basis points, eroding operating leverage.
JBI's net profit margin improvement of 1.6 percentage points, the largest among peers, signals a successful shift toward higher-margin specialty products and underpins its ROE outperformance despite stagnant asset turnover.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2026 | 9.5 | ||||||
| 2025 | 9.4 | 6.1 | 0.68 | 2.28 | 4.1 | ||
| 2024 | 13.6 | 7.3 | 0.74 | 2.51 | 13.1 | 12.6 | 5.4 |
| 2023 | 26.1 | 12.7 | 0.79 | 2.60 | 21.6 | 20.9 | 10.1 |
| 2022 | 28.7 | 10.6 | 0.80 | 3.39 | 17.5 | 16.8 | 8.5 |
| 2021 | 16.3 | 5.8 | 0.67 | 4.18 | 10.0 | 9.4 | 3.9 |
| 2020 | 40.3 | 10.4 | 0.63 | 6.20 | 12.2 | 12.1 | 6.5 |
| 2019 | 1.7 | 0.9 | 1.62 | 1.13 | -0.0 | -0.1 | 1.5 |
| 2018 | -5.0 | 0.0 |
The decline in free cash flow margin to 4.5% of revenue (down from 6.2% in FY23) stems from higher interest expense after the 2023 bond issuance; if earnings volatility persists, this could constrain JBI's ability to sustain its dividend payout ratio.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2026 | 40 | 56 | 58 | 27 | 68 | |
| 2025 | 539 | 0 | 0 | 0 | ||
| 2024 | 493 | 34 | 60 | 44 | 35 | 60 |
| 2023 | 462 | 29 | 77 | 35 | 35 | 70 |
| 2022 | 455 | 38 | 70 | 31 | 29 | 78 |
| 2021 | 546 | 41 | 63 | 20 | 40 | 65 |
| 2020 | 581 | 27 | 58 | 21 | 32 | 53 |
| 2019 | 225 | 28 | 54 | 19 | 0 | 82 |
| 2018 | 0 | 0 | 0 | 0 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2026 | ||||||||
| 2025 | $1305M | $732M | $572M | $623M | $428M | $194M | $422M | $119M |
| 2024 | $1301M | $782M | $519M | $654M | $504M | $149M | $386M | $137M |
| 2023 | $1350M | $830M | $520M | $667M | $496M | $172M | $463M | $174M |
| 2022 | $1271M | $895M | $375M | $714M | $635M | $78M | $363M | $153M |
| 2021 | $1122M | $854M | $268M | $718M | $705M | $13M | $214M | $140M |
| 2020 | $873M | $733M | $141M | $624M | $579M | $45M | $168M | $95M |
| 2019 | $348M | $40M | $308M | $630M | $627M | $2M | $3M | $0M |
| 2018 |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $140M | $-26M | $-69M | $-26M | $114M | $-16M | |
| 2024 | $154M | $-73M | $-103M | $-20M | $134M | $-79M | |
| 2023 | $215M | $-20M | $-102M | $-19M | $196M | ||
| 2022 | $88M | $-9M | $-15M | $-9M | $80M | ||
| 2021 | $75M | $-190M | $83M | $-20M | $55M | $-4M | |
| 2020 | $101M | $-11M | $-64M | $-6M | $95M | $-49M | |
| 2019 | $-0M | $-345M | $348M | $-9M | $-9M | $206M | $-71M |
| 2018 | $44M | $-744M | $711M | $-10M | $33M | $-30M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net